Embecta - 3 Year Stock Price History | EMBC
Historical daily share price chart and data for Embecta since 2022 adjusted for splits and dividends. The latest closing stock price for Embecta as of November 14, 2025 is 14.55.
- The all-time high Embecta stock closing price was 49.60 on March 21, 2022.
- The Embecta 52-week high stock price is 21.48, which is 47.6% above the current share price.
- The Embecta 52-week low stock price is 9.20, which is 36.8% below the current share price.
- The average Embecta stock price for the last 52 weeks is 14.03.
| Embecta Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 13.1426 | 19.5524 | 20.2089 | 9.1840 | 14.5500 | -27.03% |
| 2024 | 13.8628 | 17.6896 | 20.1124 | 9.4945 | 19.9386 | 13.55% |
| 2023 | 20.6556 | 22.8570 | 29.5939 | 11.8407 | 17.5597 | -23.11% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.843B | $1.123B |
| Embecta Corp. is a pure-play diabetes care company. Embecta is based in FRANKLIN LAKES, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $156.245B | 28.69 |
| HCA Healthcare (HCA) | United States | $108.000B | 17.88 |
| CVS Health (CVS) | United States | $100.590B | 11.57 |
| Elevance Health (ELV) | United States | $72.957B | 10.70 |
| Cencora (COR) | United States | $70.853B | 22.85 |
| Natera (NTRA) | United States | $27.695B | 0.00 |
| DiDi Global (DIDIY) | China | $25.933B | 21.19 |
| Labcorp Holdings (LH) | United States | $22.206B | 16.93 |
| Medpace Holdings (MEDP) | United States | $16.656B | 41.35 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.321B | 0.00 |
| ICON (ICLR) | Ireland | $13.200B | 13.10 |
| Solventum (SOLV) | United States | $13.047B | 12.66 |
| Viatris (VTRS) | United States | $12.566B | 4.68 |
| CochLear (CHEOY) | Australia | $11.666B | 0.00 |
| Revvity (RVTY) | United States | $10.589B | 19.50 |
| HealthEquity (HQY) | United States | $8.573B | 34.31 |
| Charles River Laboratories (CRL) | United States | $8.328B | 16.04 |
| Avantor (AVTR) | United States | $7.977B | 12.19 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.856B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.816B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.726B | 34.14 |
| Bausch + Lomb (BLCO) | Canada | $5.557B | 36.49 |
| Sotera Health (SHC) | United States | $4.548B | 21.93 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $3.768B | 66.17 |
| Alignment Healthcare (ALHC) | United States | $3.356B | 0.00 |
| Concentras Parent (CON) | United States | $2.531B | 15.80 |
| Premier (PINC) | United States | $2.325B | 22.53 |
| Progyny (PGNY) | United States | $2.105B | 41.39 |
| Organon (OGN) | United States | $1.981B | 2.09 |
| Surgery Partners (SGRY) | United States | $1.980B | 25.52 |
| Pediatrix Medical (MD) | United States | $1.943B | 11.60 |
| Establishment Labs Holdings (ESTA) | $1.882B | 0.00 | |
| PACS (PACS) | United States | $1.631B | 0.00 |
| Ardent Health (ARDT) | United States | $1.331B | 4.35 |
| Teladoc Health (TDOC) | United States | $1.255B | 0.00 |
| Omada Health (OMDA) | $1.203B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.042B | 17.06 |
| CareDx (CDNA) | United States | $0.816B | 13.34 |
| InnovAge Holding (INNV) | United States | $0.727B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.617B | 8.50 |
| Nutex Health (NUTX) | United States | $0.604B | 9.15 |
| Sonida Senior Living (SNDA) | United States | $0.601B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.508B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.439B | 0.00 |
| Enhabit (EHAB) | United States | $0.412B | 18.52 |
| Strata Critical Medical (SRTA) | United States | $0.399B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.366B | 5.50 |
| So-Young (SY) | China | $0.365B | 0.00 |
| Pomdoctor - (POM) | China | $0.362B | 0.00 |
| SBC Medicals (SBC) | United States | $0.349B | 7.64 |
| Shoulder Innovations (SI) | United States | $0.303B | 0.00 |
| Oncology Institute (TOI) | United States | $0.288B | 0.00 |
| KindlyMD (NAKA) | United States | $0.275B | 0.00 |
| Agilon Health (AGL) | United States | $0.250B | 0.00 |
| LifeMD (LFMD) | United States | $0.219B | 0.00 |
| Beauty Health (SKIN) | United States | $0.166B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.111B | 0.00 |
| DocGo (DCGO) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.019B | 6.84 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |